Innovation is a cornerstone of Bachem's success.
As a leading CDMO for Active Pharmaceutical Ingredients (API) in the areas of peptides and oligonucleotides, it is essential to be at the forefront of manufacturing process innovation. Continuous chromatography increases the capacity, quality, and sustainability of the purification process for the pharmaceutical companies that have chosen Bachem for their API manufacturing.
Watch the video to learn more about the many important benefits of multi-column countercurrent solution gradient purification (MSCGP), including higher efficiency, cost-effectiveness, and sustainability.
Featuring Ralf Eisenhuth, Principal Process Manager Chromatography, Oligonucleotides Management & Staff, Bachem
Download our whitepaper to find out more: bit.ly/3RgLtPj
---------------------------------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Learn more about our products and services at bit.ly/3LykCeY
11 окт 2024
